Maxine Gowen, PhD, GSK’s SVP, Centre of Excellence for External Drug Discovery, Keynotes at Windhover’s “Pharmaceutical Strategic Outlook” Conference on March 27-29, 2006 in New York City
Windhover Information Inc. announces Dr. Maxine Gowen, SVP, Centre of Excellence for External Drug Discovery, GlaxoSmithKline (GSK), will deliver a keynote address at Windhover’s “Pharmaceutical Strategic Outlook” (PSO) conference, March 27-29, 2006 at the Grand Hyatt Hotel in New York City. Dr. Gowen will highlight GSK’s new all-partnering research center, discussing its innovative out-partnering ideas, to over 200 senior executives from leading pharmaceutical, biotechnology, drug delivery and specialty pharmaceutical companies.
Dr. Gowen joins Robert Stein, MD, PhD, President, Roche Palo Alto, and Anthony Rosenberg, Global Head of Business Development and Licensing, Novartis Pharmaceuticals, as keynote speakers. Other speakers include Richard Pops, CEO, Alkermes; Mark McDade, CEO, Protein Design Labs; Ajit Gill, CEO, Nektar Therapeutics; Matt Emmens, CEO, Shire; and Michel de Rosen, CEO, ViroPharma.
“The Pharmaceutical Strategic Outlook conference focuses on understanding the rationale behind the best and most interesting strategic alliances and acquisitions of 2005, and will examine the outlook for 2006,” said Roger Longman, Managing Partner of Windhover Information Inc. The meeting will emphasize deal structure, using carefully-chosen case studies from recent transactions among major pharmaceutical, biotechnology, drug delivery, large molecule and specialty pharmaceutical companies. The event will examine how these organizations evaluate in-licensing opportunities and assess risk. Individual presentations will illuminate how dealmakers handle challenging contract issues like non-competes, penalties, patent rights, and change of control.
The conference will combine Windhover’s usual top level analysis of deal trends and deal design, alongside first-rate networking opportunities with senior level entrepreneurs, executives and investors throughout the three days.
To register, call Windhover Information at 203-838-4401 Ext. 237, or register on the Windhover Information Inc website at http://www.windhover.com/mktg/businesswire.htm. Through January 31, attendees registering for the conference can save $200 off the $1,995 registration fee.
About Windhover Information Inc.
Windhover Information provides critical commentary, analysis and data to the biotechnology, pharmaceutical, and medical device and diagnostic industries. Windhover magazines, newsletters, business conferences, in-depth market reports and databases all help senior executives worldwide in their decision making processes. Based in Norwalk, Conn., the privately held company also has offices in Washington, D.C.; Newport Beach, Calif.; and London, U.K.